These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 18045730)

  • 1. Thermodynamic studies and binding mechanisms of cell-penetrating peptides with lipids and glycosaminoglycans.
    Ziegler A
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):580-97. PubMed ID: 18045730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of cell-penetrating peptides with lipid model systems and subsequent lipid reorganization: thermodynamic and structural characterization.
    Alves ID; Correia I; Jiao CY; Sachon E; Sagan S; Lavielle S; Tollin G; Chassaing G
    J Pept Sci; 2009 Mar; 15(3):200-9. PubMed ID: 18985709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermodynamics of lipid interactions with cell-penetrating peptides.
    Sauder R; Seelig J; Ziegler A
    Methods Mol Biol; 2011; 683():129-55. PubMed ID: 21053127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of oligoarginine to membrane lipids and heparan sulfate: structural and thermodynamic characterization of a cell-penetrating peptide.
    Gonçalves E; Kitas E; Seelig J
    Biochemistry; 2005 Feb; 44(7):2692-702. PubMed ID: 15709783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-penetrating peptides: Nanocarrier for macromolecule delivery in living cells.
    Chugh A; Eudes F; Shim YS
    IUBMB Life; 2010 Mar; 62(3):183-93. PubMed ID: 20101631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Break on through to the other side-biophysics and cell biology shed light on cell-penetrating peptides.
    Fischer R; Fotin-Mleczek M; Hufnagel H; Brock R
    Chembiochem; 2005 Dec; 6(12):2126-42. PubMed ID: 16254940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the importance of electrostatic interactions between cell penetrating peptides and membranes: a pathway toward tumor cell selectivity?
    Jobin ML; Alves ID
    Biochimie; 2014 Dec; 107 Pt A():154-9. PubMed ID: 25107405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration without cells: membrane translocation of cell-penetrating peptides in the model giant plasma membrane vesicles.
    Säälik P; Niinep A; Pae J; Hansen M; Lubenets D; Langel Ü; Pooga M
    J Control Release; 2011 Jul; 153(2):117-25. PubMed ID: 21420454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tryptophan within basic peptide sequences triggers glycosaminoglycan-dependent endocytosis.
    Bechara C; Pallerla M; Zaltsman Y; Burlina F; Alves ID; Lequin O; Sagan S
    FASEB J; 2013 Feb; 27(2):738-49. PubMed ID: 23070606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Understanding of Physicochemical Mechanisms for Cell Membrane Penetration of Arginine-rich Cell Penetrating Peptides: Role of Glycosaminoglycan Interactions.
    Takechi-Haraya Y; Saito H
    Curr Protein Pept Sci; 2018; 19(6):623-630. PubMed ID: 29332576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
    Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
    Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the use of cell-penetrating peptides for medical and biological applications.
    Fonseca SB; Pereira MP; Kelley SO
    Adv Drug Deliv Rev; 2009 Sep; 61(11):953-64. PubMed ID: 19538995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studying the uptake of cell-penetrating peptides.
    Holm T; Johansson H; Lundberg P; Pooga M; Lindgren M; Langel U
    Nat Protoc; 2006; 1(2):1001-5. PubMed ID: 17406337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-penetrating peptides: mechanism and kinetics of cargo delivery.
    Zorko M; Langel U
    Adv Drug Deliv Rev; 2005 Feb; 57(4):529-45. PubMed ID: 15722162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane Crossing and Membranotropic Activity of Cell-Penetrating Peptides: Dangerous Liaisons?
    Walrant A; Cardon S; Burlina F; Sagan S
    Acc Chem Res; 2017 Dec; 50(12):2968-2975. PubMed ID: 29172443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S4(13)-PV cell-penetrating peptide forms nanoparticle-like structures to gain entry into cells.
    Padari K; Koppel K; Lorents A; Hällbrink M; Mano M; Pedroso de Lima MC; Pooga M
    Bioconjug Chem; 2010 Apr; 21(4):774-83. PubMed ID: 20205419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proline-rich, amphipathic cell-penetrating peptides.
    Pujals S; Giralt E
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):473-84. PubMed ID: 18187229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chances and pitfalls of cell penetrating peptides for cellular drug delivery.
    Tréhin R; Merkle HP
    Eur J Pharm Biopharm; 2004 Sep; 58(2):209-23. PubMed ID: 15296950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of amphipathic CPPs with model membranes.
    Deshayes S; Konate K; Aldrian G; Heitz F; Divita G
    Methods Mol Biol; 2011; 683():41-56. PubMed ID: 21053121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermodynamics of melittin binding to lipid bilayers. Aggregation and pore formation.
    Klocek G; Schulthess T; Shai Y; Seelig J
    Biochemistry; 2009 Mar; 48(12):2586-96. PubMed ID: 19173655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.